OSUR OraSure Technologies, Inc. Stock Quote

OSUR [NASD]

Healthcare | Medical Instruments & Supplies | USA

Index	-	P/E	-	EPS (ttm)	-0.15	Insider Own	0.20%	Shs Outstand	72.02M	Perf Week	-8.71%
Market Cap	643.97M	Forward P/E	33.21	EPS next Y	0.26	Insider Trans	0.00%	Shs Float	70.81M	Perf Month	-21.90%
Income	-10.70M	PEG	-	EPS next Q	-0.16	Inst Own	95.00%	Short Float	4.91%	Perf Quarter	-22.25%
Sales	233.00M	P/S	2.76	EPS this Y	-182.50%	Inst Trans	4.14%	Short Ratio	4.04	Perf Half Y	-10.12%
Book/sh	5.38	P/B	1.62	EPS next Y	325.00%	ROA	-2.30%	Target Price	14.17	Perf Year	-27.98%
Cash/sh	2.50	P/C	3.48	EPS next 5Y	20.00%	ROE	-2.70%	52W Range	8.58 - 15.94	Perf YTD	-17.81%
Dividend	-	P/FCF	-	EPS past 5Y	-28.80%	ROI	-4.10%	52W High	-45.42%	Beta	-0.33
Dividend %	-	Quick Ratio	4.40	Sales past 5Y	7.50%	Gross Margin	55.20%	52W Low	1.40%	ATR	0.48
Employees	570	Current Ratio	5.30	Sales Q/Q	12.30%	Oper. Margin	3.10%	RSI (14)	31.67	Volatility	5.67% 4.86%
Optionable	Yes	Debt/Eq	0.01	EPS Q/Q	-	Profit Margin	-4.60%	Rel Volume	1.96	Prev Close	8.94
Shortable	Yes	LT Debt/Eq	0.01	Earnings	Nov 03 AMC	Payout	-	Avg Volume	860.09K	Price	8.70
Recom	2.30	SMA20	-9.70%	SMA50	-16.15%	SMA200	-16.49%	Volume	1,687,453	Change	-2.68%

Sep-22-21

Downgrade

Raymond James

Outperform → Mkt Perform

Aug-21-20

Initiated

Evercore ISI

Outperform

$22

Aug-10-20

Initiated

JP Morgan

Neutral

$18

Aug-10-20

Initiated

Citigroup

Buy

$18

Aug-07-20

Upgrade

Raymond James

Mkt Perform → Outperform

$16

Jun-25-20

Initiated

Lake Street

Buy

$19

Apr-21-20

Resumed

Stephens

Equal-Weight

$14

Oct-23-18

Resumed

Raymond James

Mkt Perform

Jul-16-18

Downgrade

Stephens

Overweight → Equal-Weight

Nov-02-17

Downgrade

Jefferies

Buy → Hold

Feb-09-17

Upgrade

Raymond James

Mkt Perform → Outperform

Jun-13-16

Downgrade

Raymond James

Outperform → Mkt Perform

Nov-05-15

Reiterated

Mizuho

Buy

$12 → $8

May-07-15

Downgrade

JMP Securities

Mkt Outperform → Mkt Perform

Jan-23-15

Reiterated

Mizuho

Buy

$10 → $12

Jun-12-14

Reiterated

Canaccord Genuity

Buy

$10 → $11

Jun-11-14

Reiterated

Mizuho

Buy

$9 → $10

Dec-21-12

Initiated

Mizuho

Buy

Aug-08-12

Upgrade

Barrington Research

Mkt Perform → Outperform

$12.50

Jul-05-12

Downgrade

Barrington Research

Outperform → Mkt Perform

Nov-30-21 07:05AM	OraSure Technologies Remains Committed to the Global Fight Against HIV 40 Years After the Discovery of the HIV Virus GlobeNewswire
Nov-19-21 07:05AM	OraSure Technologies to Present at Upcoming Investor Conferences GlobeNewswire
Nov-11-21 09:34AM	OraSure Technologies (NASDAQ:OSUR) Is Reinvesting At Lower Rates Of Return Simply Wall St.
Nov-09-21 07:05AM	OraSure Technologies Announces the Retirement of Jack E. Jerrett and Appointment of Agnieszka M. Gallagher as General Counsel, Chief Compliance Officer and Secretary GlobeNewswire
Nov-08-21 07:05AM	OraSure Technologies Appoints Two New Members to the Board of Directors GlobeNewswire
Nov-04-21 12:31AM	Orasure Technologies Inc (OSUR) Q3 2021 Earnings Call Transcript Motley Fool -7.36%
Nov-03-21 07:15PM	OraSure Technologies (OSUR) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:05PM	OraSure Technologies Reports 3Q21 Revenue of $53.9 Million, Signs Three Major U.S. Government Contracts Positioning the Company for Significant InteliSwab Growth in FY22 GlobeNewswire
Nov-02-21 12:25PM	FDA Authorizes OraSure's COVID-19 Rapid Tests For OTC Single-Use Benzinga
07:05AM	U.S. FDA Authorizes InteliSwab COVID-19 Rapid Tests for OTC Single-Use, At-Home Testing for Symptomatic People and Accepts Data for Delta Variant Detection GlobeNewswire
Oct-27-21 03:03PM	Analysts Estimate OraSure Technologies (OSUR) to Report a Decline in Earnings: What to Look Out for Zacks
07:05AM	OraSure Technologies 2021 Third Quarter Earnings Conference Call Wednesday, November 3, 2021, 5:00 p.m. ET GlobeNewswire
Oct-04-21 03:39PM	OraSure Wins $109M Contract To Increase COVID-19 Test Manufacturing Capacity Benzinga
01:52PM	Orasure gets $109M government contract, plans to open additional manufacturing facility American City Business Journals
12:08PM	Implied Volatility Surging for OraSure Technologies (OSUR) Stock Options Zacks
07:05AM	OraSure Awarded $109 Million Contract from U.S. Department of Defense to Ramp Manufacturing of InteliSwab COVID-19 Rapid Test GlobeNewswire
Sep-23-21 10:00AM	OraSure Secures $13.6M BARDA Funding For InteliSwab COVID-19 Test 510(k) Clearance and CLIA Waiver Benzinga
08:10AM	OraSure to Receive up to $13.6 Million from Biomedical Advanced Research Development Authority to Support InteliSwab COVID-19 Rapid Test 510(k) Clearance and CLIA Waiver GlobeNewswire
Sep-20-21 06:00AM	OraSure Receives $205 Million Procurement Contract for InteliSwab from the Defense Logistics Agency to Supply Over-the-Counter (OTC) Kits as Part of National Pandemic Response GlobeNewswire
Sep-10-21 11:14AM	OraSure Technologies, Inc.'s (NASDAQ:OSUR) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? Simply Wall St. +8.77%
Sep-02-21 07:00AM	OraSure Technologies Announces Resignation of CFO Roberto Cuca and Succession Plan GlobeNewswire
Aug-03-21 11:01PM	Orasure Technologies Inc (OSUR) Q2 2021 Earnings Call Transcript Motley Fool
06:25PM	OraSure Technologies (OSUR) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:05PM	OraSure Technologies Reports 2Q21 Revenue of $57.6 Million Driven by Strong Rebound in Core Business GlobeNewswire
Jul-28-21 03:04PM	OraSure Technologies (OSUR) Earnings Expected to Grow: What to Know Ahead of Q2 Release Zacks +6.91%
Jul-27-21 04:01PM	OraSure Technologies, Inc. to Hold 2021 Second Quarter Earnings Conference Call Tuesday, August 3, 2021, 5:00 p.m. ET GlobeNewswire
Jul-12-21 07:28AM	A Look At The Fair Value Of OraSure Technologies, Inc. (NASDAQ:OSUR) Simply Wall St.
Jun-17-21 04:05PM	OraSure Technologies to Present at the Raymond James 2021 Human Health and Innovation Conference GlobeNewswire
Jun-14-21 06:00AM	OraSure and the Will Rodgers Liver Health Foundation to Heighten Awareness Around the Importance of Hepatitis C Testing GlobeNewswire
Jun-07-21 10:38AM	OraSure's COVID-19 Rapid Antigen Tests Gets FDA Emergency Approval for OTC, Professional, Prescription Use Benzinga
09:18AM	OraSure Technologies Receives Three Emergency Use Authorizations for its COVID-19 Rapid Antigen Tests for Non-Prescription (OTC), Professional and Prescription Use GlobeNewswire
May-28-21 07:00AM	OraSure Technologies to Present at the Jefferies Virtual Healthcare Conference GlobeNewswire
May-26-21 09:21AM	OraSure Resubmits EUA Applications for ELISA COVID-19 Antibody Test Benzinga
May-18-21 07:00AM	OraSure Technologies to Present at the UBS Global Healthcare Virtual Conference GlobeNewswire
May-17-21 07:00AM	OraSure Technologies Appoints Scott Gleason As Senior Vice President Investor Relations and Corporate Communications GlobeNewswire
May-12-21 06:00AM	OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 18, 2021 GlobeNewswire
03:16AM	It's Unlikely That The CEO Of OraSure Technologies, Inc. (NASDAQ:OSUR) Will See A Huge Pay Rise This Year Simply Wall St.
May-10-21 06:00AM	Insignia and Partners Support CDC Demonstration Project for Uptake of Self-test Kits for HIV GlobeNewswire
May-06-21 01:01AM	Orasure Technologies Inc (OSUR) Q1 2021 Earnings Call Transcript Motley Fool +7.87%
May-05-21 05:25PM	OraSure Technologies (OSUR) Beats Q1 Earnings and Revenue Estimates Zacks
04:00PM	OraSure Technologies, Inc. Announces First Quarter 2021 Financial Results and Provides COVID-19 Update GlobeNewswire
03:15PM	OraSure Technologies, Inc. to Host Earnings Call ACCESSWIRE
09:47AM	If You Had Bought OraSure Technologies' (NASDAQ:OSUR) Shares A Year Ago You Would Be Down 40% Simply Wall St.
Apr-30-21 04:01PM	OraSure Technologies to Hold 2021 First Quarter Earnings Conference Call Wednesday, May 5, 2021, 5:00 p.m. ET GlobeNewswire
Apr-28-21 12:34PM	OraSure Technologies (OSUR) Earnings Expected to Grow: What to Know Ahead of Q1 Release Zacks
Mar-30-21 07:00AM	OraSure Technologies Submits COVID-19 Rapid Antigen Prescription Home Self-Test and Professional Test to FDA for Emergency Use Authorization GlobeNewswire
Mar-10-21 10:29AM	Raymond James: These 3 Stocks Are Poised to Surge by at Least 50% TipRanks
Mar-01-21 08:31PM	Orasure Technologies Inc (OSUR) Q4 2020 Earnings Call Transcript Motley Fool
06:45PM	OraSure Technologies (OSUR) Q4 Earnings Miss Estimates Zacks
04:49PM	Recap: OraSure Technologies Q4 Earnings Benzinga
04:15PM	OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update GlobeNewswire
03:15PM	OraSure Technologies, Inc. to Host Earnings Call ACCESSWIRE
Feb-26-21 10:09AM	OraSure Technologies's Earnings: A Preview Benzinga
Feb-24-21 04:01PM	OraSure Technologies to Present at the Raymond James 42nd Annual Institutional Investors Conference GlobeNewswire +5.14%
Feb-18-21 06:00AM	2020 Fourth Quarter Earnings Conference Call Monday, March 1, 2021, 5:00 p.m. ET GlobeNewswire
Feb-10-21 12:31PM	OraSure Technologies (OSUR) to Report Q4 Results: Wall Street Expects Earnings Growth Zacks
Jan-29-21 06:00AM	OraSure Subsidiary DNA Genoteks OMNIgene®·ORAL Included in EUA Granted to Ambry Genetics for Use in COVID-19 RT-PCR Saliva Test GlobeNewswire
Jan-28-21 08:02AM	Smith+Nephew's (SNN) PICO sNPWT Study Outcome Encouraging Zacks
06:00AM	OraSure Subsidiary DNA Genoteks OMNIgene®·ORAL Saliva Collection Device Receives Health Canada Authorization for use in COVID-19 Testing GlobeNewswire
Jan-27-21 08:55AM	Allscripts (MDRX) Extends Tie-Up With US Orthopedic Alliance Zacks
Jan-26-21 07:57AM	OraSures OMNIgene®·ORAL Saliva Collection Kit Selected by Chronomics for Use in UK Government Test to Release for International Travel COVID-19 Testing Program GlobeNewswire
Jan-25-21 06:00AM	Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigens Scientific Advisory Board GlobeNewswire
Jan-21-21 09:46AM	Hill-Rom (HRC) to Boost Cardiology Portfolio with New Buyout Zacks
06:00AM	OraSures Oragene®Dx Saliva Collection Kit Included in Industrys First FDA Authorization for a Whole Exome Sequencing Platform GlobeNewswire
Jan-14-21 08:34AM	Aphria (APHA) Looks Good: Stock Adds 6% in Session Zacks
Jan-08-21 06:00AM	OraSure Technologies Announces 2021 Annual Meeting Date GlobeNewswire
Jan-05-21 06:00AM	OraSure Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire +6.60%
Dec-23-20 06:00AM	OraSures OMNIgene®·ORAL Device Included in EUA Amendment Granted to 3B BlackBio Biotech India for SARS-CoV-2 Test GlobeNewswire
Dec-21-20 04:01PM	OraSure Technologies Provides Update on Its Emergency Use Authorization Application for Its Lab-based Oral Fluid SARS-CoV-2 Antibody Test GlobeNewswire +5.50%
Nov-30-20 07:00AM	OraSure Technologies to Present at the 2020 Evercore ISI HealthCONx Conference GlobeNewswire
07:00AM	OraSure Technologies to Commemorate World AIDS Day by Ringing NASDAQ Closing Bell GlobeNewswire
Nov-12-20 07:00AM	OraSure Technologies to Present at the Stephens Annual Investment Conference 2020 GlobeNewswire
Nov-09-20 03:52PM	Stock Upgrades: Orasure Technologies Shows Rising Relative Strength Investor's Business Daily
08:02AM	Clinical Reference Laboratory to Market Most Cost-Effective, Gold-Standard Self-Collected COVID-19 Saliva Test Directly to Consumers PR Newswire
Nov-06-20 08:59AM	OraSure Technologies, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year Simply Wall St. +5.30%
Nov-04-20 06:05PM	OraSure Technologies (OSUR) Beats Q3 Earnings and Revenue Estimates Zacks
04:01PM	OraSure Technologies, Inc. Announces Third Quarter 2020 Financial Results and Provides Update on COVID-19 Developments GlobeNewswire
03:15PM	OraSure Technologies, Inc. to Host Earnings Call ACCESSWIRE
Nov-03-20 07:00AM	OraSures DNA Genotek Subsidiary Receives FDA Emergency Use Authorization for its ORAcollect®·RNA Saliva Collection Device for SARS CoV-2 GlobeNewswire
Oct-28-20 12:32PM	Analysts Estimate OraSure Technologies (OSUR) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-21-20 06:00AM	OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call Wednesday, November 4, 2020, 5:00 p.m. ET GlobeNewswire -5.62%
Oct-20-20 10:17AM	Company News for Oct 20, 2020 Zacks -7.34%
Oct-19-20 11:44AM	Why OraSure Technologies Stock Is Soaring Today Motley Fool +15.42%
10:28AM	Return On Capital Employed Overview: OraSure Technologies Benzinga
06:00AM	OraSures OMNIgene®·ORAL Collection Device Receives FDA Emergency Use Authorization for SARS CoV-2 GlobeNewswire
Oct-08-20 08:51AM	Implied Volatility Surging for OraSure (OSUR) Stock Options Zacks
Oct-05-20 12:23PM	Hedge Funds Are Crazy About OraSure Technologies, Inc. (OSUR) Insider Monkey +8.01%
Sep-24-20 06:00AM	OraSures ORAcollect®·RNA Device Included in EUA Granted to Quadrant Biosciences Inc. for COVID-19 Test GlobeNewswire -8.31%
Sep-15-20 12:00PM	Former CEO of H2O+ Beauty, Former Chief Chemist of MAC Cosmetics Launch Innovative Skincare Brand Using First-Ever Scientific Microbiome Testing GlobeNewswire
Sep-03-20 04:30PM	OraSures ORAcollect®·RNA Device Included in EUA Granted to MiraDx Inc. for SARS-CoV-2 Test GlobeNewswire -5.46%
Aug-27-20 04:30PM	OraSure Technologies to Present at Upcoming Investor Conferences GlobeNewswire -19.99%
Aug-21-20 09:32AM	Benzinga's Top Upgrades, Downgrades For August 21, 2020 Benzinga +12.09%
Aug-11-20 12:39PM	Here's What OraSure Technologies, Inc.'s (NASDAQ:OSUR) Shareholder Ownership Structure Looks Like Simply Wall St. -7.84%
12:38PM	Is OraSure Technologies, Inc. (NASDAQ:OSUR) Popular Amongst Institutions? Simply Wall St.
Aug-05-20 07:15PM	OraSure Technologies (OSUR) Reports Q2 Loss, Lags Revenue Estimates Zacks
04:01PM	OraSure Technologies, Inc. Announces 2020 Second Quarter Financial Results and Update on COVID-19 Testing Programs GlobeNewswire
Aug-04-20 10:59AM	Did Hedge Funds Make The Right Call On OraSure Technologies, Inc. (OSUR) ? Insider Monkey
Jul-31-20 12:15PM	OraSures OMNIgene®·ORAL Device Included in EUA Granted to Clinical Reference Laboratory for Self-Collected SARS-CoV-2 Saliva Test GlobeNewswire
11:23AM	Clinical Reference Laboratory Receives FDA Emergency Use Authorization for Best-in-Class Self-Collected COVID-19 Saliva Test PR Newswire
Jul-29-20 12:33PM	Earnings Preview: OraSure Technologies (OSUR) Q2 Earnings Expected to Decline Zacks

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company operates in two segments, Diagnostics and Molecular Solutions. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company's principal products include OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND services, a suite of genomic services. In addition, the company offers ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, infectious disease diagnostics, pharmacogenomics, personalized medicine, microbime, and animal genetics markets. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Weber Kathleen Gallagher	EVP & BU Lead - Molecular	Dec 23	Sale	11.76	10,000	117,600	96,544	Jan 04 05:48 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience